Dexmedetomidine Up-Regulates UCP2 via Modulation of the AMPK Pathway Is Associated with Reduced ROS and Neuroprotection in Neonatal Mice with Hypoxic-Ischemic Brain Damage
Kafkas Universitesi Veteriner Fakultesi Dergisi · 2026
DOI: 10.9775/kvfd.2025.35579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kafkas Universitesi Veteriner Fakultesi Dergisi, 2026. Verfasst von Bin NIE und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
NIE, B., ZHU, M., HU, S., TAN, L., & WANG, J. (2026). Dexmedetomidine Up-Regulates UCP2 via Modulation of the AMPK Pathway Is Associated with Reduced ROS and Neuroprotection in Neonatal Mice with Hypoxic-Ischemic Brain Damage. Kafkas Universitesi Veteriner Fakultesi Dergisi. https://doi.org/10.9775/kvfd.2025.35579
Vancouver
NIE B, ZHU M, HU S, TAN L, WANG J. Dexmedetomidine Up-Regulates UCP2 via Modulation of the AMPK Pathway Is Associated with Reduced ROS and Neuroprotection in Neonatal Mice with Hypoxic-Ischemic Brain Damage. Kafkas Universitesi Veteriner Fakultesi Dergisi. 2026. doi:10.9775/kvfd.2025.35579
BibTeX
@article{NIE2026,
author = {NIE, Bin and ZHU, Min and HU, Songquan and TAN, Lei and WANG, Jintao},
title = {Dexmedetomidine Up-Regulates UCP2 via Modulation of the AMPK Pathway Is Associated with Reduced ROS and Neuroprotection in Neonatal Mice with Hypoxic-Ischemic Brain Damage},
journal = {Kafkas Universitesi Veteriner Fakultesi Dergisi},
year = {2026},
doi = {10.9775/kvfd.2025.35579}
}
EUVIMED